If cervical cancer prevention programs are to be truly effective and of
public health value, testing should always be linked to appropriate
treatment for any precancerous lesions detected.
What Lesions Need to be Treated?
There is clear consensus that high-grade squamous intraepithelial
lesions (HGSIL/CIN II–CIN III) must be treated because a majority of
these lesions, in time, progress to cancer. For low-grade squamous
intraepithelial lesions (LGSILs/CIN I), the experience in developed
countries has been that the majority of lesions will regress spontaneously
and thus do not require treatment. In situations where close followup is
not possible, however, treatment of LGSIL may be advisable, particularly
if the treatment is not highly invasive or associated with serious side
effects, complications or long-term sequellae (see below, Managing
Precancerous Disease for further discussion).
Factors Affecting Choice of Treatment
Unlike cervical cancer which peaks in later years, precancerous lesions
of the cervix occur most frequently in women who are still in their
childbearing years—30s and 40s. This fact must be kept clearly in mind
when treatment policy decisions are made. In choosing a method of
treatment for younger women with cervical dysplasia, it is also important
to recognize and consider its effect on fertility as well as its safety in
pregnancy. Other factors that need to be considered are:
- Method effectiveness
- Safety and potential side effects
- Who is allowed to (or can legally) provide treatment and what
training is required to qualify such persons
- The size, extent, severity and site of the lesion
- Acceptability of treatment offered to women
- Equipment and supplies
- Availability
- Cost/affordability
Inpatient versus Outpatient Treatment
In developed countries, treatment of early cervical changes has shifted
from use of surgery, such as cone biopsy and hysterectomy, to simpler,
safer outpatient procedures. Although still used in limited circumstances,
these inpatient surgical procedures are expensive and they require use of
significant resources for anesthesia, equipment and hospitalization for
recovery. They can be associated with serious complications, such as
hemorrhage and infection. Frequently such inpatient procedures are used
when less invasive (including operative) techniques would have sufficed.
In the USA, three outpatient procedures—cryotherapy, laser
vaporization and loop electrosurgical excision procedure (LEEP) are used,
and each has it supporters and critics. Additionally, in some countries,
electrosurgery (cauterization) is still being used. Over the years, there
has been much discussion about which of these methods is best in terms of
safety, efficacy and costs. All are outpatient procedures that can be used
either to destroy tissue (cyrotherapy, laser vaporization or
electrosurgery) or remove it (LEEP). Proponents of cryotherapy have
emphasized its reliability, ease of use, low complication rate and low
cost. Concerns about cryotherapy, electrosurgery and laser vaporization
are that they do not provide a tissue specimen that can be examined
histologically. Also compared to laser therapy, cryotherapy and
electrosurgery are not easily tailored to the size of the lesion. With
LEEP, however, the entire squamocolumnar junction (SCJ) is removed and a
surgical specimen is provided. This reduces the possibility of missing
invasive cancer.
Of these outpatient procedures, cyrotherapy, using a liquid coolant
(compressed carbon dioxide or nitrous oxide gas), and LEEP are most widely
used (Table 4). Cryotherapy, which only
freezes cells, may be the most practical for use in low-resource settings
where there are few physicians because of its simplicity and minimal
discomfort. LEEP, in addition to requiring more training and skill, is
best suited to facilities where medical backup is available because of the
small risk of postoperative bleeding. Electrosurgery, although very
inexpensive and easy to use, is associated with several side effects
(pain, usually requiring local anesthesia, and postoperative bleeding).
Finally, laser vaporization is very costly and requires more training and
skills than the other two procedures. In addition, it is associated with
more safety issues (eye injuries and unintended burns). These factors make
it unsuitable for large-scale use in low-resource settings.
Table 4. Outpatient Treatment Options
| Procedure |
Outpatient |
Anesthesia |
Electrical
Power |
Non-physicians |
Costa |
| Cryotherapy |
Yes |
No |
No |
Yes |
Low |
| Electrocautery |
Yes |
Yes
(local) |
Yes |
Yes |
Low |
| Cold
cautery (100°C) |
Yes |
Yes
(local) |
Yes |
Yes |
Low |
| LEEP |
Yes |
Yes
(local) |
Yes |
No |
High |
| Laser
vaporization |
Yes |
Yes
(local) |
Yes |
No |
High |
| Cone biopsy |
No |
Yes
(general or regional) |
Yesb |
No |
High |
| Hysterectomy |
No |
Yes
(general or regional) |
Yesb |
No |
High |
a Low = <$500,
Moderate = $500–1500, High = >$1500
b Required for use of operating room
lighting and equipment
Until recently, which of the treatment options is most effective has
been disputed. Fortunately, a randomized clinical trial conducted by
Mitchell and colleagues (1999) provides strong evidence that cyrotherapy,
laser vaporization and LEEP are equally effective with high success rates
(74–83%). In order to reduce bias in their study, all patients were
stratified by the size (area) of the lesion and by type of lesion
(histologic grade). In addition, they were followed up for a longer time
than any previous study of this type to more accurately determine the
recurrence rate. Of the 390 patients enrolled, the total surface area of
the cervix affected was one-third or less in 75% and 123 had CIN I, 124
CIN II and 143 CIN III. As shown in Table 5,
the rate of persistence plus recurrence was higher, but not statistically
significantly so, with cryotherapy (26%) than with laser therapy (17%) or
LEEP (17%) (p = 0.24). The major differences between these three treatment
options was in recurrence rates, but these differences also were not
statistically significant.
When lesion size, type of lesion and location were taken into account,
only lesion size was statistically significantly associated with higher
rates of persistence. Women with lesions covering more than two-thirds of
the surface of the cervix were 19 times more likely to have
persistent disease than those with smaller lesions, whatever procedure was
used. Other factors that increased the risk of recurrence at least two-fold
were:
- age over 30 years,
- positive HPV test (types 16 or 18), and
- previous treatment for CIN.
Although LEEP and laser therapy had higher rates of complications, 8%
and 4% respectively than cryotherapy (2%), these differences were not
statistically significant (Table 5).
Furthermore, less than 1% of women developed cervical stenosis or pelvic
infection regardless of the type of procedure used. The main difference in
complications among the procedures was the higher risk of postoperative
bleeding with LEEP (3%) versus either laser (1%) or cryotherapy (0%).
Table 5. Comparison of Treatment Options
|
Cryotherapy
(n=139) |
Laser
Vaporization (n=121) |
Leep
(n=130) |
| Effectivenessa
|
76
7
19 |
83%
4%
13% |
83%
4%
13% |
| Complications |
2% |
4% |
8% |
| Bleeding
(peri- and post-operative) |
0% |
1% |
3% |
aAt 1 year
bDisease detected within 6
months
cDisease detected after 6
months
Source: Mitchell et al 1998.
In a separate study, Montz (1996) reviewed the potential effect of these
same three procedures, plus electrocautery and surgical conization, on
infertility (Table 6). Theoretically, these
procedures could affect fertility in four ways—by cervical stenosis,
decreased volume or quality of cervical mucus, cervical incompetence and
tubal scarring or occlusion as a result of post-treatment pelvic
infection. Only conization was found to have any negative affect on
fertility resulting in an increased risk of second trimester abortion,
preterm labor and low-birthweight infants. This increased risk was found
to be related to the volume and length of endocervical tissue removed.
Because the amount of tissue destroyed or removed by cryotherapy, laser or
LEEP is small, not surprisingly these procedures had no adverse effects on
fertility or pregnancy outcome.
Table 6. Risk of Long-Term Sequellae
| Sequellae |
Cryotherapy or
LEEP |
Cone Biopsy |
Infertility
- Cervical stenosis
- Cervical incompetence
- Decreased cervical mucus
- Tubal scarring
|
No
No
No
No |
Yes
Yes
Yes
Yes |
Pregnancy outcome
- 2nd trimester abortion
- Preterm labor
- Low birthweight
|
No
No
No |
Yes
Yes
Yes |
Source: Montz 1996.
In summary, several procedures are available for outpatient,
localized treatment of precancerous cervical lesions. Success rates are
comparable but capital expenses, maintenance costs, the need for local
anesthesia, side effects and complication rates vary considerably for each
procedure. And, with the exception of cryotherapy, all require electrical
power. Although cryotherapy has become less popular in the USA in recent
years, this has more to do with: 1.) the attraction of physicians to
high-tech equipment (laser vaporization and LEEP); 2.) the perception that
laser/LEEP is significantly more effective than cryotherapy; and 3.) the
perceived need for a tissue diagnosis (biopsy specimen); than with the
failure rate of this simpler, low-tech, but less expensive procedure. For
most countries with limited resources, some combination of cryotherapy and
LEEP offer the most affordable solution to treating precancerous lesions
on a large scale. At a minimum, LEEP could be made available in referral
centers, where physicians and medical back up, local anesthesia
(paracervical block) and electrical power exist. By contrast, cryotherapy
could be made widely available in low-resource settings where only nurses
or nurse-midwives are posted and electric power is often unreliable
(Sivanesaratnam 1999). Table 7
summarizes the advantages and disadvantages of cryosurgery and LEEP.
Table 7. Advantages and Disadvantages of Cryotherapy and LEEP
| TREATMENT |
ADVANTAGES |
DISADVANTAGES |
| Cryotherapy
|
- Effective with mild and
moderate lesions (85–95% cure rate)
- Inexpensive
- Nonphysician can perform
- No local anesthesia required
- No electricity required
- Associated with few complications/side effects
- Can be performed during pregnancy
|
- Variable success rate with large, severe lesions
(70–90% cure rate)
- Destructive (leaves no tissue
sample for confirmatory diagnosis)
- Difficult to determine exact amount of tissue destroyed
- Associated with profuse watery
discharge for 4–6 weeks following
treatment
- Requires access to and resupply of coolant (CO2 or
N2O)
|
| LEEP
|
- Effective (90–96% cure rate for all lesions—more effective with severe lesions than cryotherapy)
- Enables tissue sampling for diagnosis
- Associated with few complications/side effects
|
- More expensive than cryotherapy ($4–6000)
- Primary side effect is perioperative bleeding (about 3–8%)
- Physician required to perform
- Requires local anesthesia
- Requires electricity (but could be battery powered)
- Requires resupply of loops
- Should not be performed during
pregnancy
|